Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis

American Journal of Veterinary Research

Volumn 62, Issue 11, 2001, Pages 1721-1726

  Lok, J B ^a   Knight, D H ^a   Wang, G T ^a   Doscher, M E ^a   Nolan, T J ^a   Hendrick, M J ^a   Steber, W ^a   Heaney, K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; MOXIDECTIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROSS BREEDING; DIROFILARIA IMMITIS; DOG; DRUG ADMINISTRATION; DRUG FORMULATION; DRUG SAFETY; EUTHANASIA; EXPOSURE; FEMALE; FILARIASIS; GRANULOMA; HEART; INFECTION PREVENTION; INJECTION SITE; INOCULATION; LARVA; LUNG; MALE; NONHUMAN; PALPATION; PLEURA CAVITY; PROPHYLAXIS; RELIABILITY; SEX; STAGING; SUSTAINED DRUG RELEASE; TREATMENT FAILURE; TUMOR VOLUME;

ANIMALIA; CANIS FAMILIARIS; DIROFILARIA IMMITIS;

EID: 0034755536     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.1721     Document Type: Article

References (24)

1. Prophylactic therapy against developing stages of Dirofilaria immitis
2. Extended studies on prophylactic therapy against the developing stages of Dirofilaria immitis in the dog
3. Prophylactic therapy against developing stages of Dirofilaria immitis: Supplemental studies
4. Efficacy of ivermectin against Dirofilaria immitis larvae in dogs 30 and 45 days after induced infection
5. Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development
6. Heartworm prophylaxis with moxidectin: Field trial results from a hyperenzootic area
7. Efficacy of ivermectin against Dirofilaria immitis larvae in dogs 31, 60, and 90 days after infection
8. Prophylactic activity of avermectins against experimentally induced Dirofilaria immitis infection in dogs
9. Efficacy of milbemycin oxime in chemoprophylaxis of dirofilariasis in cats
10. Prevention of naturally acquired heartworm infection in heartworm-naive beagles by oral administration of moxidectin at an interval of either one or two months
11. Prevention of experimental heartworm infection in dogs with single, oral doses of moxidectin
12. UK-124,114, a novel avermectin for the prevention of heartworms in dogs and cats
13. A review of the use of a controlled-release formulation of ivermectin in the treatment and prophylaxis of Psoroptes ovis infestation in sheep
14. Efficacy of ivermectin delivered from a sustained-release bolus against gastrointestinal nematodes in field grazing calves in Nyandarua district of Kenya
15. Delivery of ivermectin by injectable microspheres
16. Inheritance of susceptibility to Dirofilaria immitis infection in Aedes aegypti
17. Purification and site of synthesis of Aedes aegypti yolk proteins
18. In vitro cultivation of Dipetalonema viteae third-stage larvae: Evaluation of culture media, serum, and other supplements
19. Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection
20. Pharmacokinetics for the pharmaceutical scientist
21. Seasonal timing of heartworm chemoprophylaxis in the United States
22. Metabolism and tissue residues
23. Biology of Dirofilaria immitis
24. Evaluation of ivermectin and milbemycin oxime efficacy against Dirofilaria immitis infections of three and four months' duration in dogs